ゲノム研究:知識と商業化に対する公衆の期待を満たす
1National Institutes of Health, Bethesda, MD 20892.
まとめ
この記事では,遺伝子配列の特許を検証し,特許法の進化とその学術研究と技術移転への影響について考察しています. 急速な技術的進歩の中で,ゲノム研究のために慎重に政策を採択することは極めて重要です.
科学分野:
- バイオテクノロジー法 バイオテクノロジー法
- 知的財産権 知的財産権とは
- ゲノム研究ゲノム研究
背景:
- 遺伝子配列特許の歴史的文脈.
- 特許法の基本と進化.
- 連邦技術移転法と政策の概要.
研究 の 目的:
- 学術研究における遺伝子特許の影響を評価する.
- 遺伝子配列の特許可否を検証する.
- 下流製品の特許保護に対する公開されたシーケンスデータの影響を分析する.
主な方法:
- 特許法の歴史的分析.
- 連邦の技術移転政策の見直し.
- 遺伝子特許に関する産業の視点と公共の記録の検討.
主要な成果:
- 遺伝子特許は著しく進化し,学術研究と技術移転に影響を与えています.
- 遺伝子配列の特許権は,特に公表されたデータで,複雑な課題を提示します.
- 業界と公衆の観点から,慎重に政策を策定する必要性を強調しています.
結論:
- ゲノム研究のための技術移転政策は,慎重で適応可能な実施を必要とする.
- イノベーションとアクセスのバランスをとることは,進化する遺伝子特許の景観の鍵です.
- 戦略的特許出願とライセンス取得は,ゲノム学における進歩にとって極めて重要です.
関連する概念動画
Genomic DNA in Eukaryotes
Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


